Long-term Remote Ischemic Preconditioning Improve Long-term Prognosis of Acute Myocardial Infarction Patients Without Emergency Reperfusion Therapy
|ClinicalTrials.gov Identifier: NCT02843464|
Recruitment Status : Unknown
Verified July 2016 by Xuanwu Hospital, Beijing.
Recruitment status was: Not yet recruiting
First Posted : July 25, 2016
Last Update Posted : January 12, 2017
|Condition or disease||Intervention/treatment||Phase|
|Myocardial Infarction||Other: reported remote ischemic preconditioning (RIPC)||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||220 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Study Start Date :||December 2016|
|Estimated Primary Completion Date :||July 2018|
Experimental: long-term RIPC group
routine treatment + once RIPC/day for a year. Three five-minute cycles of upper limb ischaemia and three five-minute pauses using a blood pressure cuff inflated to 200 mmHg.
Other: reported remote ischemic preconditioning (RIPC)
Three five-minute cycles of upper limb ischaemia and three five-minute pauses using a blood pressure cuff inflated to 200 mmHg.
No Intervention: control group
- The major adverse cardiovascular events (MACE) include cardiovascular death, spontaneous myocardial infarction, unplanned revascularization and stroke. [ Time Frame: one year ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02843464
|Contact: Zhi Liu, firstname.lastname@example.org|